Oasis新闻发布

策略、交易设想或案例研究中的任何示例仅供说明和讨论之用，未必代表历史或未来的投资策略，或者任何具体投资策略的表现或成功几率。不保证本文所提及投资机会将在未来成为现实。不应假设任何投资模型提及的投资项目一旦实施定能盈利，因为这些假设未必能够成真。本文提及的任何具体投资项目或案例研究，其选择依据是非投资表现类客观标准，仅供介绍投资流程和Oasis用于评估这类投资项目所做的分析工作。历史投资（包括出现资金亏损的投资）清单可应要求提供。一如既往，过往表现未必是未来业绩的指示。

February 2024

Aeon’s long-held dream of conducting a major drugstore industry reorganization under the banner of fostering ‘global companies’

《日经新闻》

Aeon’s long-held dream of conducting a major drugstore industry reorganization under the banner of fostering ‘global companies’

Welcia-Tsuruha merger sparks drugstore industry reorganization: A major alliance worth 2 trillion yen in [annual] sales is born

Tsuruha Holdings to become part of Aeon and merge with Welcia Holdings by end of 2027

Competition Intensifies: Restructuring looms closer – Tsuruha to become part of Aeon – Trigger for talks with ‘activist shareholder’

JAE share price down by 3% due to continued selling following the rejection of Oasis’ injunction over soon-to-expire tender offer

Japan retailer Aeon to merge with drugstore chains Tsuruha and Welcia

Hazama Ando tops expected dividends ranking despite decrease in net profit – Financial Results Ranking (#2): Expected dividend yields for the fiscal year ending March 31, 2024

The Present and Future of Governance – Tokyo Disney operator’s shares targeted again; Mitsui Fudosan invests as part of its ‘core business’

Fund files injunction against NEC’s sale of subsidiary shares

Tsuruha HD shares temporarily up 14% on possibility of merger with Welcia HD

Hong Kong investor files court injunction on NEC’s JAE stake sale

Oasis files injunction to stop NEC from tendering shares as part of JAE buyback

Oasis files injunction against NEC’s application to JAE tender offer

Tsuruha and Welcia merger being considered: With Aeon as a shareholder, the resulting company would become Japan’s 4th-largest retailer

Drugstores becoming increasingly ‘mega-sized’: Welcia x Tsuruha merger under consideration; resulting company would be Japan’s 4th-largest retailer

Oasis says it opposes Taisho Pharma’s $5bln management buyout

Oasis opposes Taisho Pharmaceutical MBO, says price is ‘too low’

More global activists than ever before, particularly at Japanese and European companies

Retail reshuffling reflects shrinking domestic consumption

Aeon Co. leads retail restructuring: industry to witness birth of drugstore coalition worth ¥2 trillion in annual sales amid [Aeon’s] acquisition of Tsuruha shares, increasing stake to more than 25%

Aeon to increase its stake in Tsuruha to 26%, negotiating with Hong Kong fund to potentially create major alliance

Aeon to buy more Tsuruha shares, negotiating with fund in hopes of creating giant drugstore alliance

Aeon negotiating to acquire shares in Tsuruha, which together with industry leader Welcia would bring total [annual] sales to more than 2 trillion yen… will there be an industry reorganization?

Aeon begins exclusive negotiations with Oasis for acquisitions of Tsuruha shares

Japan’s Aeon in exclusive talks to buy Tsuruha stake from Oasis

As China’s markets stumble, Japan rises toward record

Activist shareholders triple presence in 5 years, following Japanese firms’ P/B ratio reforms

Fujitec to announce new medium-term management plan in May, following management changes

Tender offer for Itochu subsidiary causes another stir: Another chance for Oasis

Are the ‘black ships’ friend or foe? The companies entrusting activists to serve on their boards of directors